Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers

被引:26
作者
Weber, GF
Ashkar, S
机构
[1] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Harvard Univ, Sch Med, Dept Orthoped Surg, Childrens Hosp,Lab Skeletal Disorders & Rehab, Boston, MA USA
关键词
invasion; homing receptors; cytokines; proteinases; stress response;
D O I
10.1016/S0361-9230(00)00379-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cancer is characterized by dysregulated growth control, overcoming of replicative senescence, and metastasis formation. Tumor dissemination distinguishes malignant from benign neoplasms and is mediated by homing receptors, their ligands, and proteinases. The homing receptor CD44 is frequently expressed on primary brain tumors and brain metastases, Its engagement by osteopontin physiologically induces macrophage chemotaxis, a mechanism that may be utilized by metastatic brain tumors in the process of dissemination, In host defense, osteopontin and its receptors, CD44 and integrin alpha (V)beta (3), play key roles in mediating delayed type hypersensitivity responses by activating macrophages to induce Th1 cytokines while inhibiting Th2 cytokines, Other metastasis associated gene products similarly contribute to host defenses. Hence, cancer spread is regulated by a set of developmentally nonessential genes which physiologically mediate stress responses, inflammation, wound healing, and neovascularization. Function of the relevant gene products is extensively modified post-transcriptionally and their dysregulation in cancer occurs on the levels of expression and splicing. Consistent patterns of organ preference by malignancies of particular tissue origin suggest a necessary connection between loss of growth control and senescence genes and expression of genes mediating the dissemination of tumor cells. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:421 / 424
页数:4
相关论文
共 28 条
[1]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[2]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[3]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[4]   Glioma invasion in the central nervous system [J].
Giese, A ;
Westphal, M .
NEUROSURGERY, 1996, 39 (02) :235-250
[5]   The extracellular matrix of gliomas: Modulation of cell function [J].
Gladson, CL .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (10) :1029-1040
[6]   Cell-extracellular matrix interaction in glioma invasion [J].
Goldbrunner, RH ;
Bernstein, JJ ;
Tonn, JC .
ACTA NEUROCHIRURGICA, 1999, 141 (03) :295-305
[7]   CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix [J].
Henke, CA ;
Roongta, U ;
Mickelson, DJ ;
Knutson, JR ;
McCarthy, JB .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2541-2552
[8]   THE CDNA AND DERIVED AMINO-ACID SEQUENCE FOR HUMAN OSTEOPONTIN [J].
KIEFER, MC ;
BAUER, DM ;
BARR, PJ .
NUCLEIC ACIDS RESEARCH, 1989, 17 (08) :3306-3306
[9]   THE PUERAP MOTIF IN THE PROMOTER OF THE MOUSE OSTEOPONTIN GENE [J].
KIMBRO, KS ;
SAAVEDRA, RA .
OSTEOPONTIN: ROLE IN CELL SIGNALLING AND ADHESION, 1995, 760 :319-320
[10]   DIFFERENTIAL EXPRESSION OF THE CD44 MOLECULE IN HUMAN BRAIN-TUMORS [J].
KUPPNER, MC ;
VAN MEIR, E ;
GAUTHIER, T ;
HAMOU, MF ;
DETRIBOLET, N .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (04) :572-577